Skip to main content
. 2019 Jul 17;12(1):116–127. doi: 10.1159/000500420

Fig. 4.

Fig. 4

miR-498 was increased in nasal mucosal tissues from AR patients and in IL-13-treated NECs. a The expression levels of miR-498 in mucosal tissues from 30 AR patients and 30 healthy controls were measured by qRT-PCR. b The expression levels of miR-498 in NECs after IL-13 stimulation (50 ng/mL) for 24 h were measured by qRT-PCR. ** p < 0.01; *** p < 0.001. AR, allergic rhinitis; NECs, nasal epithelial cells; IL-13, interleukin-13.